AUTHOR=Li Wen-shan , Zhang Qing-qing , Li Qiao , Liu Shang-yu , Yuan Guo-qiang , Pan Ya-wen 

TITLE=Innate immune response restarts adaptive immune response in tumors

JOURNAL=Frontiers in Immunology

VOLUME=Volume 14 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1260705

DOI=10.3389/fimmu.2023.1260705

ISSN=1664-3224

ABSTRACT=Abstract：The imbalance of immune response plays a crucial role in the development of diseases, including glioblastoma. It is essential to comprehend how the innate immune system detects tumors and pathogens. Endosomal and cytoplasmic sensors can identify diverse cancer cell antigens, triggering the production of type I interferon and pro-inflammatory cytokines. This, in turn, stimulates interferon stimulating genes, enhancing the presentation of cancer antigens, and promoting T cell recognition and destruction of cancer cells. While RNA and DNA sensing of tumors and pathogens typically involve different receptors and adapters, their interaction can activate adaptive immune response mechanisms. This review highlights the similarity in RNA and DNA sensing mechanisms in the innate immunity of both tumors and pathogens. The aim is to enhance the anti-tumor innate immune response, identify regions of the tumor that are not responsive to treatment, and explore new targets to improve the response to conventional tumor therapy and immunotherapy. 【Keywords】DNA sensing, RNA sensing, Crosstalk, glioblastoma, Type I interferon Background: Tumor pathogenesis is caused by mutations in proto-oncogenes and tumor suppressors. One significant aspect of cancer pathogenesis is the disruption of the host immune system. Tumors employ various mechanisms to evade immune surveillance and destruction. These mechanisms include creating an immunosuppressive microenvironment, impairing T-cell signaling, and up-regulating immune checkpoints that prevent attacks on normal cells [1] . However, not all cancers respond well to immunotherapy, and some are better at evading immune surveillance, known as immune 'silencing' or 'cold' tumors [2]  . Recent research has shown that T cells switch between IS/IK states, undergoing a cycle of symmetrization and symmetry-breaking. When immunopathology occurs, the immune system's focus on